• A fine-tuned gene editor that minimizes adverse consequences

    10 days ago - By Phys

    The molecular tool CRISPR-Cas9 can be used to treat inherited blood disorders, but this may cause unintended genetic alterations. A team led by MDC researchers Klaus Rajewsky and Van Trung Chu has now presented an approach in Science Advances that minimizes such adverse consequences.
    Read more ...